Market Overview

Jefferies Downgrades Ampio Pharmaceuticals To Hold

Related AMPE
Mid-Afternoon Market Update: Dow Rises More Than 200 Points; Shares Gain Following Alphabet Investment
10 Biggest Mid-Day Losers For Thursday

Analysts at Jefferies downgraded Ampio Pharmaceuticals (NYSE: AMPE) from Buy to Hold.

The target price for Ampio Pharmaceuticals has been lowered from $14 to $5.

Ampio Pharmaceuticals shares have fallen 15.02% over the past 52 weeks, while the S&P 500 index has surged 19.77% in the same period.

Ampio Pharmaceuticals' shares rose 0.71% to $5.70 in pre-market trading.

Latest Ratings for AMPE

Aug 2014JefferiesDowngradesBuyHold
Jun 2014JefferiesInitiates Coverage onBuy
May 2014Citigroup

View More Analyst Ratings for AMPE
View the Latest Analyst Ratings

Posted-In: JefferiesDowngrades Analyst Ratings


Related Articles (AMPE)

View Comments and Join the Discussion!